Dottikon Es Holding AG
SIX:DESN

Watchlist Manager
Dottikon Es Holding AG Logo
Dottikon Es Holding AG
SIX:DESN
Watchlist
Price: 216.5 CHF Market Closed
Market Cap: 3B CHF
Have any thoughts about
Dottikon Es Holding AG?
Write Note

Gross Margin
Dottikon Es Holding AG

65.5%
Current
73%
Average
23.7%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
65.5%
=
Gross Profit
216.6m
/
Revenue
330.7m

Gross Margin Across Competitors

Country CH
Market Cap 3B CHF
Gross Margin
66%
Country US
Market Cap 87.2B USD
Gross Margin
48%
Country US
Market Cap 68.1B USD
Gross Margin
43%
Country JP
Market Cap 10.2T JPY
Gross Margin
38%
Country CH
Market Cap 36.4B CHF
Gross Margin
43%
Country CN
Market Cap 235.1B CNY
Gross Margin
15%
Country US
Market Cap 32.3B USD
Gross Margin
36%
Country US
Market Cap 28.1B USD
Gross Margin
42%
Country CH
Market Cap 25.9B EUR
Gross Margin
25%
Country IN
Market Cap 2.2T INR
Gross Margin
43%
Country DK
Market Cap 165.6B DKK
Gross Margin
54%
No Stocks Found

Dottikon Es Holding AG
Glance View

Market Cap
3B CHF
Industry
Chemicals

Dottikon Es Holding AG stands as one of Switzerland's understated gems in the realm of fine chemicals and pharmaceuticals. Born from Switzerland's rich tradition of precision and quality, the company operates primarily in the realm of exclusive synthesis, tailored to meet the stringent demands of the pharmaceuticals industry. At its core, Dottikon specializes in hazardous chemical reactions, priding itself on an ability to transform complex chemical processes into high-quality results. This specialization provides a competitive edge, allowing Dottikon to focus on developing innovative and complex molecules which serve as active pharmaceutical ingredients (APIs). It's a business model that not only underscores the company's technical expertise but also its commitment to safety and environmental stewardship, given the heightened risks associated with hazardous materials. Revenue for Dottikon is chiefly generated from strategic partnerships with major pharmaceutical companies. By offering a unique combination of research and development capabilities coupled with state-of-the-art production facilities, Dottikon caters to bespoke needs, from initial developmental scales to full-fledged commercial production runs. The trust and collaboration between Dottikon and its clients are pivotal, as the company becomes an indispensable partner in the clients’ supply chain. As the pharmaceutical sector continues to evolve and demand for specialized molecules increases, Dottikon’s focus on exclusivity and expertise positions it well within the industry, ensuring steady demand and solidifying its role as a reliable, albeit lesser-known, catalyst in advancing pharmaceutical innovations.

DESN Intrinsic Value
163.42 CHF
Overvaluation 25%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
65.5%
=
Gross Profit
216.6m
/
Revenue
330.7m
What is the Gross Margin of Dottikon Es Holding AG?

Based on Dottikon Es Holding AG's most recent financial statements, the company has Gross Margin of 65.5%.